Ongoing: Every 3-4 months, repeat hormone panels and metabolic labs
Market participants are expanding production capacity through new facilities, reactor installations, purification infrastructure, and strategic long-term manufacturing agreements with pharmaceutical companies
(Both the Part D out-of-pocket spending cap and Medicare drug price negotiations were established under the Inflation Reduction Act of 2022.) The full analysis, and other data and analyses about Medicare spending on prescription drugs, is available at kff.org.
NHS and NICE-aligned measures include eating smaller, more frequent meals, avoiding fatty or spicy foods, remaining upright after eating, and using alginate preparations such as Gaviscon Advance as a first-line option
Potential for complications and ongoing monitoring